|
- 2015
子宫内膜腺癌中EMT的发生及miR200a/ZEB1信号通路在该过程中发挥的作用
|
Abstract:
[1] | Garofalo M, Croce CM. Role of microRNAs in maintaining cancer stem cells[J]. Adv Drug Deliv Rev, 2015, 81:53-61. doi: 10.1016/j.addr.2014.11.014. Epub 2014 Nov 20. |
[2] | Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis[J]. RNA Biol, 2008, 5(3):115-119. |
[3] | Kinose Y, Sawada K, Nakamura K, et al. The role of microRNAs in ovarian cancer[J]. Biomed Res Int, 2014, 2014: 249393 . doi: 10.1155/2014/249393. Epub 2014 Sep 10. |
[4] | Li X, Roslan S, Johnstone CN, et al. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways[J]. Oncogene, 2014, 33(31):4077-4088. |
[5] | Chen Y, Xiao Y, Ge W, et al. miR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells[J]. Cell Death Dis, 2013, 4:e541.doi: 10.1038/cddis.2013.22. |
[6] | Vella LJ. The emerging role of exosomes in epithelial-mesenchymal-transition in cancer[J]. Front Oncol, 2014, 4:361. |
[7] | Azueta A, Gatius S, Matias-Guiu X. Endometrioid carcinoma of the endometrium: pathologic and molecular features[J]. Semin Diagn Pathol, 2010, 27(4):226-240. |
[8] | Ombrato L, Malanchi I. The EMT universe: space between cancer cell dissemination and metastasis initiation[J]. Crit Rev Oncog, 2014, 19(5):349-361. |
[9] | Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: “plastic surgeons” of breast cancer[J]. World J Clin Oncol, 2014, 5(3):311-322. |
[10] | Vergara D, Merlot B, Lucot JP, et al. Epithelial-mesenchymal transition in ovarian cancer[J]. Cancer Lett, 2010, 291(1):59-66. |
[11] | Giannoni E, Bianchini F, Masieri L, et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness[J]. Cancer Res, 2010, 70(17):6945-6956. |
[12] | 刘苹, 李平, 彭艳, 等. 原代成纤维细胞和纤维肉瘤细胞自分泌转化生长因子β1浓度检测及对转化生长因子β1增殖的调节[J]. 中国组织工程研究与临床康复, 2011, 15(41):7669-7672. LIU Ping, LI Ping, PENG Yan, et al. Detection of autocrine transforming growth factor-beta β1 concentration in the primary fibroblasts and fibrosarcoma cells and effects on cell proliferation[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2011, 15(41):7669-7672. |
[13] | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29. |
[14] | Abal M, Llaurado M, Doll A, et al. Molecular determinants of invasion in endometrial cancer[J]. Clin Transl Oncol, 2007, 9(5):272-277. |
[15] | Heldin CH, Vanlandewijck M, Moustakas A. Regulation of EMT by TGFbeta in cancer[J]. FEBS Lett, 2012, 586(14):1959-1970. |
[16] | 洪伦. 上皮-间质转化及相关microRNA分子与肿瘤的恶性行为的研究进展[J]. 中国癌症杂志, 2011, 21(9):725-730. HONG Lun. EMT phenomenon and related microRNAs in the malignant progression of tumor[J]. China Oncology, 2011, 21(9):725-730. |
[17] | Zhu QC, Gao RY, Wu W, et al. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer[J]. Asian Pac J Cancer Prev, 2013, 14(5):2689-2698. |
[18] | Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition[J]. Mol Biol Cell, 2011, 22(10):1686-1698. |